Home
Live Updates
Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Womens Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs -March 11, 2024 at 07:31 am EDT : comparemela.com
Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women's Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs -March 11, 2024 at 07:31 am EDT
Late-breaking oral presentation of a subgroup analysis in RAMP 201 Part A heavily pretreated patients receiving avutometinib and defactinib and their best response compared to most recent prior...
Related Keywords
San Diego ,
California ,
United States ,
Michelle Greenman ,
Racheln Grisham ,
Dan Paterson ,
Charlottec Sun ,
Susanna Banerjee ,
Exchange Commission ,
Drug Administration ,
Patient Impact ,
Genfleet Therapeutics Shanghai Inc ,
Linkedin ,
Raf And Mek Program ,
Chugai Pharmaceutical Co Ltd ,
Society Of Gynecologic Oncology ,
Secura Bio Inc ,
Company Annual Report On Form ,
Amgen ,
Verastem Oncology ,
Gynecologic Oncology ,
Impact Survey ,
Data Presentations ,
Scientific Plenary ,
Late Breaking Abstract Session ,
Rare Cancer ,
Uncommon Cancers ,
Poster Session ,
Progress Poster ,
Breakthrough Therapy ,
Orphan Drug Designation ,
Secura Bio ,
Genfleet Therapeutics ,
Annual Report ,
comparemela.com © 2020. All Rights Reserved.